CEL-SCI Corp (CVM)
0.6005
0.00 (0.00%)
USD |
NYAM |
Nov 22, 11:50
CEL-SCI Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2011 | -4.02K% |
| March 31, 2011 | -32.02K% |
| December 31, 2010 | -943.1% |
| September 30, 2010 | -11.86K% |
| June 30, 2010 | -1.95K% |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | -56.27K% |
| March 31, 2008 | |
| December 31, 2007 | -120.4K% |
| September 30, 2007 | -4.69K% |
| June 30, 2007 | -86.14K% |
| March 31, 2007 | -11.02K% |
| December 31, 2006 | -8.02K% |
| September 30, 2006 | -22.62K% |
| June 30, 2006 | -3.26K% |
| March 31, 2006 | -3.62K% |
| December 31, 2005 | -4.20K% |
| September 30, 2005 | -14.91% |
| June 30, 2005 | -1.72K% |
| Date | Value |
|---|---|
| March 31, 2005 | -1.05K% |
| December 31, 2004 | -1.63K% |
| September 30, 2004 | |
| June 30, 2004 | -1.10K% |
| March 31, 2004 | -1.21K% |
| December 31, 2003 | -1.51K% |
| September 30, 2003 | -2.90K% |
| June 30, 2003 | -2.85K% |
| March 31, 2003 | -1.25K% |
| December 31, 2002 | -3.18K% |
| September 30, 2002 | -1.78K% |
| June 30, 2002 | -2.45K% |
| March 31, 2002 | -2.74K% |
| December 31, 2001 | -1.94K% |
| September 30, 2001 | |
| June 30, 2001 | -958.0% |
| March 31, 2001 | -4.13K% |
| December 31, 2000 | -1.02K% |
| September 30, 2000 | -435.6% |
| June 30, 2000 | -216.5M% |
| March 31, 2000 | -3.62K% |
| December 31, 1999 | -170.0M% |
| September 30, 1999 | -733.3% |
| June 30, 1999 | -1.70K% |
| March 31, 1999 | -2.10K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -10.57K% |
| IGC Pharma Inc | -416.7% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Protalix BioTherapeutics Inc | 18.02% |
| Palatin Technologies Inc | -- |